Health and Medical News - Page 33

Page 33 of Health and Medical News issued by the Send2Press® Newswire service.



Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine

SAN MARINO, Calif. – Dec. 18 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation announced today their appreciation of the accomplishments of their contemporaries in 2007, a truly remarkable year in terms of biomedical research, scholarship, and gonzo journalism. It was a year in which a definitive meeting entitled ‘In Vivo Barriers to Gene Delivery’ was held at the prestigious Cold Spring Harbor Laboratory, where Nobel laureate James Watson presides, or shall we say presided.

ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G, a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer

SAN MARINO, Calif. – Dec. 17 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation announced today that the company has received a Certificate of Product Registration for Rexin-G(R) from the Philippine Bureau of Food and Drugs (BFAD), enabling the commercialization of its lead product as a safe and effective treatment for a broad spectrum of intractable cancers. Developed as a tumor-targeted anticancer agent, that actively seeks out and destroys metastatic cancers, Rexin-G exhibits unprecedented single-agent efficacy.

As More Americans Live to 100, Long Term Care Insurance Leader Gives Health Assist

KIRKLAND, Wash. – Dec. 14 (SEND2PRESS NEWSWIRE) — As Americans increase their life spans, many eyeing 100-plus, the odds of needing long term care increase. One solution is long term care insurance to pay the care bills. ‘A better solution,’ says Cameron Truesdell, CEO of LTC Financial Partners (LTCFP), ‘is the insurance plus health habits to keep yourself on your feet as long as possible.’

Announcing the Launch of Affinity Healthcare

BUFFALO GROVE, Ill. – Dec. 4 (SEND2PRESS NEWSWIRE) — The internal medicine/family practice medical group practices formerly named Greater Northwest Medical Group, North Suburban Internists and Adult Care Specialists have merged to become Affinity Healthcare, LLC.

New Book Reveals Ways to Enhance and Alter Skin Color

SAN FRANCISCO, Calif. (SEND2PRESS NEWSWIRE) — The old adage that ‘beauty is only skin deep’ is true, but diet and lifestyle make it possible to change the skin’s color, if so desired. ‘Unlocking the Mystery of Skin Color’ (ISBN: 978-0-9792103-0-3), a new book scheduled to be released by Thienna, Inc., in mid-December, provides tips on how to control and to change the skin’s color.

Michigan Medical Spa Offers VIP Membership

STERLING HEIGHTS, Mich. – Nov. 28 (SEND2PRESS NEWSWIRE) — Accents Cosmetic Surgery & Medical Spa in Sterling Heights, Michigan has become the first Detroit-based Medical Spa to offer an exclusive VIP membership program. Dozens of men and women have already signed up and committed to caring for their skin and addressing their cosmetic flaws in 2008.

Home for the Holidays – It May Not Be as Joyful for Your Older Relatives

SUNRISE, Fla. – Nov. 27 (SEND2PRESS NEWSWIRE) — The holiday season is here. For some, plans are in motion to visit elderly family members. But if it has been a while since you last visited, you might be shocked at how much they have aged, concerned about their continued safety and well-being and motivated to do something about it, say the folks at Interim HealthCare.

Local Interim HealthCare Wellness Clinic Saves Lives

SUNRISE, Fla. – Nov. 26 (SEND2PRESS NEWSWIRE) — The local Interim HealthCare office of Columbus, OH, frequently holds Wellness Clinics for the community. However, it is not everyday when a wellness screening can save a person’s life. That is what happened to two lucky citizens this past Fall at Free Diabetes Clinics offered at two different Kroger stores in the Columbus area.

New Report Examines Pharmaceutical Sales Force Effectiveness

LONDON, U.K. and NEW YORK, N.Y. – Nov. 20 (SEND2PRESS NEWSWIRE) — With the ever-increasing pressure to ensure maximum return on investment, sales force effectiveness is becoming a high priority in the global pharmaceutical industry. Reports have shown that while sales forces represent the largest spend in pharma sales and marketing, return on this investment has declined sharply in recent years.

Always Best Care Senior Services Expands into Cleveland, Ohio

CLEVELAND, Ohio – Nov. 5 (SEND2PRESS NEWSWIRE) — Always Best Care Senior Services has expanded into Cleveland, Ohio. America’s premier In-Home Care, Assisted Living Placement Service, and Personal Response Company, is proud to announce seniors in Cleveland can now rely on Always Best Care Senior Services for outstanding care.

FDA Approves the Opening of a Phase II Registration Protocol Using REXIN-G(R) for Osteosarcoma in California U.S.A.

SAN MARINO, Calif. – Nov. 5 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation announced today that the company has taken a major step toward the commercialization of its lead product with the opening of a Phase II Registration Protocol using Rexin-G for osteosarcoma in the United States. Following the accelerated approval of Rexin-G for the treatment of all solid tumors by the Bureau of Food and Drugs in the Philippines.

Always Best Care Senior Services Expands into Santa Barbara

SANTA BARBARA, Calif. – Nov. 2 (SEND2PRESS NEWSWIRE) — Always Best Care Senior Services has expanded into the Santa Barbara area. America’s premier In-Home Care, Assisted Living Placement Service, and Personal Response Company, is proud to announce seniors in Santa Barbara can now rely on Always Best Care Senior Services for outstanding care.

Announcing Always Best Care Senior Services Expansion into the Littleton / Denver, Colorado Area

DENVER, Colo. – Oct. 31 (SEND2PRESS NEWSWIRE) — Always Best Care Senior Services has expanded into the Littleton/Denver, Colorado area. America’s premier In-Home Care, Assisted Living Placement Service, and Personal Response Company, is proud to announce seniors in Littleton/Denver can now rely on Always Best Care Senior Services for outstanding care.

Announcing Always Best Care Senior Services Expansion Into San Joaquin County, California

SACRAMENTO, Calif. – Oct. 31 (SEND2PRESS NEWSWIRE) — Always Best Care Senior Services has expanded into the San Joaquin County, California area. America’s premier In-Home Care, Assisted Living Placement Service, and Personal Response Company, is proud to announce seniors in San Joaquin County can now rely on Always Best Care Senior Services for outstanding care.

DCH Auto Group Dedicates Hospital Childcare Center

FREEHOLD, N.J. – Oct. 15 (SEND2PRESS NEWSWIRE) — DCH Freehold Toyota and parent company, DCH Auto Group, dedicated the Childcare Center at CentraState’s new Fitness and Wellness Center on Saturday. John T. Gribbin, President and CEO of CentraState Healthcare System, thanked DCH for its ongoing contribution, presenting a plaque in recognition of DCH’s generosity.

Peoria Fertility Center Announces Change in Management

PEORIA, Ill. – Oct. 4 (SEND2PRESS NEWSWIRE) — The Sher Institutes for Reproductive Medicine (SIRM(TM)) have announced that Dr. Milton McNichol will assume the role of Medical Director of SIRM-Central Illinois, located in Peoria. Dr. McNichol is a board certified Reproductive Endocrinologist who joins SIRM-Central Illinois from an infertility practice in Shawnee Mission.

Eularis Announces New Corporate Name and Expanded Product Offerings

NEW YORK, N.Y. and LONDON, U.K. – Sept. 24 (SEND2PRESS NEWSWIRE) — Campbell Belman, an established pharmaceutical analytics company, today introduces its new name: Eularis. This announcement reflects the significant growth the Company has achieved across its full range of pharmaceutical analytics products, which have helped tailor the advertising and marketing programs of its global top-tier clients.

Previser Launches New Website and Enhanced Version of its Oral Disease and Risk Assessment Software

MOUNT VERNON, Wash. – Sept. 24 (SEND2PRESS NEWSWIRE) — PreViser Corporation, a world leader in risk and disease analysis software that enhances treatment planning for patients affected by oral disease, announced a simultaneous release of a new corporate website and a major upgrade to its software. PreViser’s version 3.0 software is now both Windows- and Macintosh-compatible.

New Treatments for Kidney Cancer Offer Hope, but Create Difficult Choices for Cancer Patients

SAN FRANCISCO, Calif. – Sept. 7 (SEND2PRESS NEWSWIRE) — California Kidney Cancer Foundation Executive Director, Dr. David Minor will present a review of treatments for metastatic kidney cancer as presented at the most recent American Society of Clinical Oncology Conference. The presentation will be from 3 to 5 PM on September 15, 2007 at California Pacific Medical Center, 2333 Buchanan Street, San Francisco, Calif.

MMDI’s Rebound HRD(TM) Receives FDA 510(k) Clearance

MINNEAPOLIS, Minn. – Aug. 21 (SEND2PRESS NEWSWIRE) — Minnesota Medical Development, Inc. (MMDI) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to its new Rebound HRD(TM) (Hernia Repair Device). The Rebound HRD is intended to assist in the repair and/or reinforcement of hernia or other soft tissue defects where weakness exists and where the support of a nonabsorbable material is preferred.

CYNACON/OCuSOFT (OCuSOFT, Inc.) Names Edward J. Holland, M.D. to Medical Scientific Advisory Board

RICHMOND, Texas – Aug. 15 (SEND2PRESS NEWSWIRE) — CYNACON / OCuSOFT (OCuSOFT, Inc.), a company specializing in ophthalmic research, development and supply to ophthalmologists and optometrists, is pleased to announce the appointment of Edward J. Holland, M.D. to its Medical Scientific Advisory Board.

Baker County Medical Services Posts Its Charges on Their Website

MACCLENNY, Fla. – Aug. 9 (SEND2PRESS NEWSWIRE) — Baker County Medical Services which operates Ed Fraser Memorial Hospital in Macclenny, Florida announced today that they have posted all of their hospital charges contained in their Charge Master on their website bcmedsvcs.com.

Ophthalmic Research and Development Company Launches Adjunctive Eyelid Therapy and Hygiene Product

RICHMOND, Texas – Aug. 6 (SEND2PRESS NEWSWIRE) — CYNACON /OCuSOFT(R) (OCuSOFT, Inc.) specializes in ophthalmic research, development and supply to ophthalmologists and optometrists. They are excited to announce a new and innovative prescription-only ALODOX(R) Convenience Kit for adjunctive eyelid therapy and hygiene.

CYNACON/OCuSOFT (OCuSOFT, Inc.) Names Lawrence A. Yannuzzi, M.D. to Medical Scientific Advisory Board

RICHMOND, Texas – Aug. 3 (SEND2PRESS NEWSWIRE) — CYNACON / OCuSOFT (OCuSOFT, Inc.), a company specializing in ophthalmic research, development and supply to ophthalmologists and optometrists, today announced the appointment of Lawrence A. Yannuzzi, M.D. to its Medical Scientific Advisory Board.

iPhone Browses Diagnostic Heart Images

DURHAM, N.C. – July 16 (SEND2PRESS NEWSWIRE) — Heart Imaging Technologies (HeartIT) announced today that medical images can be viewed on Apple’s new iPhone (see examples at heartit.com). Physicians can simply click on a web link sent via email by one of their colleagues, enter their password, and, for example, instantly view movies of a patient’s beating heart halfway around the world.

California Biotechnology Company Takes Aim at Pancreatic Cancer With an Advanced Phase I/II Clinical Trial Using Rexin-G(TM), a Targeted Injectable Gene Delivery System

SAN MARINO, Calif. – July 10 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation announced today that an advanced Phase I/II clinical trial using intravenous Rexin-G(TM) for pancreatic cancer that is refractory to standard chemotherapy will open in the summer of 2007 in Los Angeles, California. Rexin-G is the world’s first tumor-targeted injectable gene delivery system that is designed to seek out and destroy both primary tumors and metastatic cancers.

The National Children’s Oral Health Foundation and Previser Announce Initiative to Reduce Oral Disease Among Disadvantaged Populations

CHARLOTTE, N.C. – July 10 (SEND2PRESS NEWSWIRE) — The National Children’s Oral Health Foundation (NCOHF), and PreViser Corporation, today announced a joint initiative to collaborate in an effort to improve the oral health of low income children nationwide. The NCOHF’s non-profit mission is to eliminate oral disease, and promote overall health and well-being for economically disadvantaged children.

Gel Smart/Pedifix Introduces the First Anatomically Designed All Gel Digital Cap

WHIPPANY, N.J. – June 21 (SEND2PRESS NEWSWIRE) — Gel Smart/Pedifix has introduced the first anatomically designed All-Gel Digital Cap recommended for soothing as well as protecting fingers and toes. The All-Gel Digital Cap provides superior cushioning and protection and relief for corns, calluses, nails, cuticles, hammer toes and partially amputated digits.

Osmetech Licenses Self-Assembling Monolayer (SAM) Technology to Minerva Biotechnologies Corporation

PASADENA, Calif. – June 18 (SEND2PRESS NEWSWIRE) — Osmetech plc (LSE, AIM; OMH) today announced that it has granted a non-exclusive research license to Waltham, Massachusetts, US-based Minerva Biotechnologies Corporation (‘Minerva’) for use of Osmetech’s self-assembling monolayer (SAM) technology in conjunction with Minerva’s proprietary nanoparticle technology.

HearPod, Inc. Provides Baby Boomers with Quality Hearing Aid Options

CORNELIUS, N.C. – June 15 (SEND2PRESS NEWSWIRE) — Communication is the foundation for an incredible life at work, with friends, and especially at home. That’s why so many baby boomers are turning to HearPod 32X to power up their hearing. Baby boomers have a reputation for expecting the best and many will not settle for less. However, cost can sometimes interfere when purchasing a quality hearing aid.

Mark Whitacre, Ph.D. Joins Management Team at Cypress Systems, Inc.

FRESNO, Calif. – June 13 (SEND2PRESS NEWSWIRE) — Cypress Systems, Inc, a Fresno CA based biotechnology company, announced that it has hired Mark Whitacre, Ph.D. Dr. Whitacre joined the executive management team effective January 1, 2007 as COO & President, Technology and Business Development, following the opening of a new office in Pensacola, Florida in December, 2006.

U.S. Pharmaceuticals Spend $8 Billion Annually in R&D Conducted Overseas – New Clintelligence(R) Alignment Module Advances Global Management

KENILWORTH, N.J. – June 12 (SEND2PRESS NEWSWIRE) — 3C Company, Inc., a leading provider of Business Performance Optimization (BPO) solutions to the Life Sciences Industry, announces today the release of a new module to its highly successful Clintelligence(R) Business Intelligence Solution.

Crescent Diagnostics Announces Positive Clinical Results for its Novel Bone Quality Test, BQT(TM)

LONDON, UK – June 8 (SEND2PRESS NEWSWIRE) — Crescent Diagnostics Ltd (‘Crescent’), today announced the publication of a recent study demonstrating the potential of the Bone Quality Test, BQT(TM) to diagnose osteoporosis. More women at risk can be screened with an accurate, simple to use test which does not require a hospital visit.

Osmetech Licenses Roche Hot Start(R) Polymerase Technology

PASADENA, Calif. – June 5 (SEND2PRESS NEWSWIRE) — Osmetech plc (AIM; LSE: OMH) today announced that it has been granted a non-exclusive worldwide diagnostics license from Swiss-based F. Hoffman LaRoche Ltd and its US affiliate Roche Molecular Systems Inc. (collectively ‘Roche’) to use Hot Start(R) polymerase technology in Osmetech nucleic acid diagnostic assays.

News from the Battlefield of Metastatic Cancer: Epeius Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G) from the Stone of Chemistry and Physics

SAN MARINO, Calif. – June 4 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation today announced the publication of a historic landmark in medical oncology and a definitive benchmark in the emerging field of cancer gene therapy. The first clinical report of its kind, Le Morte du Tumour – published in the June issue of the International Journal of Oncology, Vol.30, pp. 1297-1307 – documents the histologic features of tumor destruction observed in chemo-resistant cancers.

Epeius Biotechnologies Reaches Out to American Cancer Patients, Gains FDA Approval for Two New Clinical Trials Using Rexin-G(TM) for Breast Cancer and Sarcoma

SAN MARINO, Calif. – June 4 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation announced today the expansion of ongoing clinical trials using Rexin-G(TM) in the United States to include breast cancer and all types of sarcomas that have failed standard chemotherapy. Following on the heels of their landmark clinical trials in the United States and abroad, the US FDA granted Orphan Drug Status for Rexin-G.

Epeius Biotechnologies to Present the Advent of Tumor Targeting Technology and the Clinical Development of its Lead Anti-Cancer Agent, Rexin-G(TM), at Upcoming Bioventure, Nanotechnology and Nanomedicine Conferences

SAN MARINO, Calif. – May 15 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation today announced that Dr. Frederick L. Hall, President and CEO of Epeius Biotechnologies, has accepted an invitation to speak during the 9th annual C21 BioVentures Conference. On May 23 at 11:15 am, Dr. Hall will present the scientific principles, clinical validation, and global development status of the company’s innovative tumor-targeting technology embodied in its lead product, Rexin-G.

Local Pharmacy is First in New Jersey to Earn Top Quality and Safety Endorsement

WASHINGTON, D.C. – May 14 (SEND2PRESS NEWSWIRE) — Belvidere Pharmacy is the first pharmacy in the state of New Jersey to earn the Pharmacy Compounding Accreditation Board’s Seal of Accreditation – a new system of standards created by some of the leading organizations in pharmacy. The accreditation demonstrates that Belvidere Pharmacy meets the highest quality and safety standards in its profession.

Drug Development Costs Exceed $802 Million: Global Pharmas Use Clintelligence to Do Something About It

KENILWORTH, N.J. – May 2, 2007 (SEND2PRESS NEWSWIRE) — 3C Company, Inc., a leading provider of Business Performance Optimization (BPO) solutions to the Life Sciences Industry, announced today that it has aligned with yet another Global Pharmaceutical Firm to implement Clintelligence – 3C Company’s Business Intelligence Solution for strategic and tactical oversight of their Research and Development portfolio.

Alma Lasers(TM) Receives FDA Clearance for the Accent(TM) Dual Mode RF System

BUFFALO GROVE, Ill. – Apr. 30 (SEND2PRESS NEWSWIRE) — Alma Lasers a global leader in laser, light-based, and radio frequency (RF) technologies used in aesthetic medicine announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market the Accent(TM) Dual Mode RF System in the United States.